SG/CALL/AMGEN/400/0.1/21.03.25 | Market Closed - Boerse Frankfurt Warrants 15:37:50 2024-06-21 EDT | ||
| 0.54 EUR | -1.82% |
|
| Current month | -6.78% | ||
| 1 month | -26.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-21 | 0.55 | 0.00% |
| 24-06-20 | 0.55 | +14.58% |
| 24-06-19 | 0.48 | -4.00% |
| 24-06-18 | 0.5 | 0.00% |
| 24-06-17 | 0.5 | +19.05% |
Real-time Boerse Frankfurt Warrants
Last update June 21, 2024 at 03:37 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SU6V4J |
| ISIN | DE000SU6V4J6 |
| Date issued | 2024-01-10 |
| Strike | 400 $ |
| Maturity | 2025-03-21 (272 Days) |
| Parity | 10 : 1 |
| Emission price | 0.93 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.26 € |
|---|---|
| Lowest since issue | 0.21 € |
| Spread | 0.02 € |
| Spread % | 3.70% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
308.2
USD
Average target price
316.4
USD
Spread / Average Target
+2.69%
- Stock Market
- Warrants
- Warrant
